20094 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction; Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
Stable Non-Aqueous Pharmaceutical Compositions
#302Systems, devices, and methods for making or administering frozen particles
#303Systems, devices, and methods for making or administering frozen particles
#304Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
#305Systems, devices, and methods for making or administering frozen particles
#306Systems, devices, and methods for making or administering frozen particles
#307Crystalline micropowder particles
#308Systems, devices and methods for making or administering frozen particles
#309Frozen compositions and methods for piercing a substrate
#310Method for production of particles of pharmaceutical substances particles of pharmaceutical substances and the use thereof
#311Stable Non-Aqueous Pharmaceutical Compositions
#312Frozen compositions and methods for piercing a substrate
#313Vaccine formulations and uses thereof
#314Frozen compositions and methods for piercing a substrate
#315Frozen compositions and array devices thereof
#316Compositions and methods for biological remodeling with frozen particle compositions
#317Frozen compositions and methods for piercing a substrate
#318Compositions and methods for delivery of frozen particle adhesives
#319Compositions and methods for delivery of frozen particle adhesives
#320Compositions and methods for therapeutic delivery with frozen particles
#321Compositions and methods for biological remodeling with frozen particle compositions
#322Compositions and methods for biological remodeling with frozen particle compositions
#323Compositions and methods for surface abrasion with frozen particles
#324Frozen piercing implements and methods for piercing a substrate
#325Frozen compositions and methods for piercing a substrate
#326Compositions and methods for administering compartmentalized frozen particles
#327Compositions and methods for administering compartmentalized frozen particles
#328Compositions and methods for delivery of frozen particle adhesives
#329Compositions and methods for therapeutic delivery with frozen particles
#330Compositions and methods for therapeutic delivery with frozen particles
#331Compositions and methods for therapeutic delivery with frozen particles
#332Compositions and methods for surface abrasion with frozen particles
#333Compositions and methods for biological remodeling with frozen particle compositions
#334Compositions and methods for therapeutic delivery with frozen particles
#335Compositions and methods for therapeutic delivery with frozen particles
#336Compositions and methods for therapeutic delivery with frozen particles
#337Compositions and methods for surface abrasion with frozen particles
#338Method for producing particles and particles
#339Method of producing porous microparticles
#340Delta 9—tetrahydrocannabinol processing
#341Method for treating infectious organisms normally considered to be resistant to an antimicrobial drug
#342Process for Preparation of a Stable Dispersion of Solid Amorphous Submicron Particles in an Aqueous Medium
#343Pharmaceutical preparations and their manufacture
#344Method for producing coenzyme Q10 particle
#345COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A LEUKOTRIENE RECEPTOR ANTAGONIST FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#346COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A PDE-4 INHIBITOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#347MASKING THE TASTE OF POWDERS
#348Medical devices and methods including polymers having biologically active agents therein
#349COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH AN ANTI-IGE ANTIBODY FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#350APREPITANT COMPOSITIONS
#351COMPOSITIONS OF GLYCOPYRRONIUM SALT FOR INHALATION
#352Compositions and methods for the delivery of poorly water soluble drugs and methods of treatment
#353PHARMACEUTICAL COMPOSITIONS OF ATORVASTATIN
#354INHALABLE DRUG
#355Solubilized ibuprofen
#356Gabapentin-containing solid compositions and process for preparing the same
#357Pharmaceutical compositions
#358Delivery of active agents
#359DEVICE FOR INHALATION OF MEDICINE
#360Methods of crystallizing antibodies
#361DEHYDROEPIANDROSTERONE SULFATE DIHYDRATE INHALATION COMPOSITIONS AND METHODS
#362Pharmaceutical formulation for contraception and hormone-replacement therapy
#363PULMONARY DELIVERY OF POLYENE ANTIFUNGAL AGENTS
#364NANOCLUSTERS FOR DELIVERY OF THERAPEUTICS
#365Process for the manufacture of powders of inhalable medicaments
#366NANOCLUSTERS FOR DELIVERY OF THERAPEUTICS
#367SUBMICRONIZATION OF PROTEINS USING SUPERCRITICAL FLUIDS
#368Storage stable powder compositions of interleukin-4 receptor
#369Nucleic acid microparticles for pulmonary delivery
#370Solid Amorphous Dispersions of An Mtp Inhibitor For Treatment of Obesity
#371Method of creating crystalline substances
#372Method of Production of Fine-Crystalline Mixture Containing Non-Steroid Anti-Inflammatory Drug, Fine-Crystalline Mixture Obtainable by this Method and Solid Pharmaceutical Composition Containing this Mixture
#373Method for production of directly compressible ibuprofen formulations
#374Microparticle preparation and medical composition
#375RECOMBINANT EUKARYOTIC CELLS STABLY EXPRESSING (SID-1) PROTEINS FOR HIGH THROUGHPUT GENE SCREENING
#376Method and apparatus for producing dry particles
#377Porous substances and methods for producing the same
#378Method for precipitation of small medicament particles into use containers
#379USE OF ADSORBENT CARBON MICROSPHERES TO TREAT GASTROESOPHOGEAL REFLUX DISEASE
#380Nanoparticles comprising a nanoparticle template and a polymer shell having an amide side chain, and method of making thereof
#381Controlled release formulations
#382Compositions comprising calcium citrate malate and methods for making the same
#383Compositions comprising calcium citrate malate and methods for making the same
#384Inhalation Powder Containing the CGRP antagonist BIBN4096 and Process for the Preparation Thereof
#385Product Comprising a Beta-Lactam Antibiotic
#386Enteric coated granule and method for preparing the same
#387Eggplant extract for medical treatments
#388Methods of preparing pimecrolimus
#389Production of porous materials by supercritical fluid processing
#390Granules Comprising a Beta-Lactam Antibiotic
#391Antisolvent Emulsion Solidification Process
#392High Pressure Compaction For Pharmaceutical Formulations
#393Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
#394PHARMACEUTICAL COMPOSITIONS IN PARTICULATE FORM
#395Nanoclusters for delivery of therapeutics
#396Method of manufacturing a granular mineral composition
#397Method And Apparatus For Producing Particles Via Supercritical Fluid Processing
#398Insulin highly respirable microparticles
#399Method for producing antibiotic/antibiotics and their use
#400Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation
#401Formulation and manufacturing process for calcium acetate capsules
#402COMPOSITIONS AND METHODS FOR THE PULMONARY DELIVERY OF AEROSOLIZED MEDICAMENTS
#403Storage stable power compositions of interleukin-4 receptor
#404Device, method and use for the formation of small particles
#405Solid particulate tadalafil having a bimodal particle size distribution
#406Method for production of enzyme granules and enzyme granules produced thus
#407Process for the production of particles
#408Devices, Compositions and Methods for the Pulmonary Delivery of Aerosolized Medicaments
#409Microparticles
#410Complexation of metal ions with polypeptides
#411Process
#412Coated particles for sustained-release pharmaceutical administration
#413Methods for preparing pharmaceutical compositions
#414SURFACE-MODIFIED MICROPARTICLES AND METHODS OF FORMING AND USING THE SAME
#415Amorphous form of losartan potassium
#416Methods for fine powder formation
#417Novel process
#418Antisolvent solidification process
#419Ascomycin crystalline forms and preparation thereof
#420Non-hygroscopic and powdery amorphous pimecrolimus
#421Extended release, multiple unit dosage forms of phenytoin sodium and processes for their preparation
#422Methods of preparing pimecrolimus
#423Method of forming particles
#424Processes for producing crystalline macrolides
#425Submicron suspensions with polymorph control
#426Production of small particles
#427Enzyme granulate production method and resulting enzyme granulates
#428Agglomerates by crystallisation
#429Method of providing customized drug delivery systems
#430Method and apparatus for the formation of particles
#431Pharmaceutical compositions delivery system and methods
#432Method and apparatus for producing dry particles
#433Methotrexate compositions
#434Agglomeration of sterol particles
#435High ibuprofen content granules and their preparation and their use in pharmaceutical dosage forms
#436Protein microspheres having injectable properties at high concentrations
#437Synthesis and powder preparation of fluticasone propionate
#438Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
#439Pharmaceutical products, preparation and uses thereof
#440Applicatin of a bioactive agent in a solvent composition to produce a target particle morphology
#441Crystal forms of azithromycin
#442Crystal forms of azithromycin
#443Formulation for inhalation
#444Crystal forms of azithromycin
#445Process and apparatus for producing inhalable medicaments
#446Porous substances and methods for producing the same
#447Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen product
#448Aggregates of human insulin derivatives
#449Lecithin-containing granular compositions and methods of their preparation
#450Process for producing fine medicinal substance
#451Method of producing hollow, microporous particles which are intended, in particular to be inhaled
#452Methods and apparatus for making particles using spray dryer and in-line jet mill
#453Method of particle formation
#454Rotor-stator apparatus and process for the formation of particles
#455Crystal forms of azithromycin
#456Stable amorphous forms of montelukast sodium
#457Interleukin-13 antagonist powders, spray-dried particles, and methods
#458Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
#459Nanoparticulate therapeutic biologically active agents
#460Compositions and methods for timed release of water-soluble nutritional supplements, green coffee extract
#461Process of forming and modifying particles and compositions produced thereby
#462Stable salts of o-acetylsalicylic acid containing basic amino acids II
#463Methods for encapsulating small spherical particles prepared by controlled phase separation
#464Method for preparing submicron particle suspensions
#465Tocopheryl polyethylene glycol succinate articles and process for preparing TPGS articles
#466Synthesis of small particles
#467Preparation of small crystals
#468Biocompatible protein particles, particle devices and methods thereof
#469Methods for encapsulating small spherical particles prepared by controlled phase separation
#470Method for the production and the use of microparticles and nanoparticles by constructive micronisation
#471Storage stable powder compositions of interleukin-4 receptor
#472Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom
#473Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
#474Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
#475Methods for micronization of hydrophobic drugs
#476Crystal forms of azithromycin
#477Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
#478ApO2 ligand/TRAIL formulations
#479Porous drug matrices and methods of manufacture thereof
#480Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
#481Porous drug matrices and methods of manufacture thereof
#482Powder formulation containing the CGRP antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2 (1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin, process for preparing and the use thereof as inhalation powder
#483Process for forming amorphous atorvastatin
#484Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
#485Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
#486Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
#487Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
#488Pharmaceutical formulation for contraception and hormone-replacement therapy
#489Apo-2 ligand/trail formulations
#490Preparation of microparticles
#491Doxycycline metal complex in a solid dosage form
#492Method for the the formation of ibuprofen crystals
#493Microparticles
#494Synthesis of metal nanoparticles using an extract of terfeziaceae
#495Drug particles from freezing onto a surface